|Articles|February 2, 2017
Emergent BioSolutions
Advertisement
Emergent BioSolutions provides contract manufacturing services for the aseptic fill/finish of vials and syringes: liquid and lyophilized products. Emergent’s sterile injectable manufacturing facility (located in Baltimore, MD) currently produces 20 commercial products and since 1998 has contributed to the development and production of over 200 clinical products.
INTERPHEX Booth #1240
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Full Autonomy Is a ‘No-Go Zone’: Setting Parameters for Agentic AI in Pharma
2
A Year of Advancements in the Treatment of Cancer
3
PharmTech’s Top 10 Articles of 2025
4
The Year of the Tariff: Pharmaceutical Supply Chain Reimagined in 2025
5